New Technology “Vaporizes” Blockages in the Arteries


By: Daniel Trecroci

Peripheral arterial disease (PAD) affects up to 12 million Americans, causing symptoms that range from leg pain to gangrene or ulcerations resulting from lack of blood flow. Untreated, PAD can lead to possible amputation.

A new laser technology may provide an alternative to amputation. Unlike bypass surgery or angioplasty and stenting techniques, the CLiRpath laser can vaporize blockages in the arteries in the leg and foot. According to a press release by CLiRpath maker Spectranetics Corp., in clinical trials, limb salvage was observed in 95 percent of patients surviving to six months in people doing CLiRpath therapy.

For more information, visit the Web site at



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.